moxifloxacin has been researched along with Endomyometritis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, T; Kitaya, K; Sakuraba, Y; Tanaka, SE | 1 |
Alcaraz, I; Bertolotti, A; Derancourt, C; Dupin, N; Janier, M; Milpied, B | 1 |
1 trial(s) available for moxifloxacin and Endomyometritis
Article | Year |
---|---|
Multi-drug-resistant chronic endometritis in infertile women with repeated implantation failure: trend over the decade and pilot study for third-line oral antibiotic treatment.
Topics: Anti-Bacterial Agents; Azithromycin; Chronic Disease; Embryo Implantation; Endometritis; Endometrium; Female; Humans; Infertility, Female; Moxifloxacin; Pharmaceutical Preparations; Pilot Projects; Prospective Studies; Retrospective Studies | 2022 |
2 other study(ies) available for moxifloxacin and Endomyometritis
Article | Year |
---|---|
[Mycoplasma genitalium].
Topics: Anti-Bacterial Agents; Azithromycin; Endometritis; Female; Fluoroquinolones; Humans; Male; Moxifloxacin; Mycoplasma genitalium; Mycoplasma Infections; Salpingitis; Urethritis; Uterine Cervicitis; Vaginosis, Bacterial | 2016 |
Moxifloxacin: new indication. Do not use in gynaecological infections or other conditions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Double-Blind Method; Endometritis; Europe; Female; Fluoroquinolones; Humans; Moxifloxacin; Pelvic Inflammatory Disease; Quinolines; Randomized Controlled Trials as Topic; Salpingitis | 2009 |